For the Inventor, By the Inventor

Enter assignee name

La Jolla, CA, United States of America

Intellikine LLC

USPTO Granted Patents = 34

CIPO Patents = 40

EPO Patents = 17

Forward Citations = 578

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Yi Liu (33 out of 149 patents)

Pingda Ren (32 out of 136 patents)

Troy Edward Wilson (31 out of 55 patents)

4. Liansheng Li (27 out of 114 patents)

5. Katrina Chan (25 out of 47 patents)

6. Christian Rommel (16 out of 16 patents)

7. Simon F Campbell (4 out of 52 patents)

8. Michael Martin (3 out of 11 patents)

9. Katayoun Jessen (3 out of 8 patents)

10. Xin Guo (3 out of 7 patents)

11. Lynne Bui (2 out of 4 patents)

12. Andrew Gaheem Hsieh (1 out of 21 patents)

13. Kevan M Shokat (1 out of 49 patents)

14. Davide Ruggero (1 out of 4 patents)

15. David Fruman (1 out of 1 patent)

34 patents: Sort by Forward Citations

1. 11433065 - Certain chemical entities, compositions and methods (2022-09-06),

2. 10172858 - Combination pharmaceutical compositions and uses thereof (2019-01-08),

3. 9828378 - Kinase inhibitors and methods of use (2017-11-28),

4. 9822131 - Certain chemical entities, compositions and methods (2017-11-21),

5. 9790228 - Heterocyclic kinase inhibitors (2017-10-17),

6. 9682141 - Combination of kinase inhibitors and uses thereof (2017-06-20),

7. 9669032 - Enhanced treatment regimens using mTOR inhibitors (2017-06-06),

8. 9655892 - Certain chemical entities, compositions and methods (2017-05-23),

9. 9637492 - Benzothiazole kinase inhibitors and methods of use (2017-05-02),

10. 9629843 - MTOR modulators and uses thereof (2017-04-25),

11. 9522146 - Substituted Isoquinolin-1(2H)-one compounds, compositions, and methods thereof (2016-12-20),

12. 9403820 - Kinase inhibitor polymorphs (2016-08-02),

13. 9359352 - Substituted benzimidazoles as PI3 kinase inhibitors (2016-06-07),

14. 9359349 - Substituted quinazolines as kinase inhibitors (2016-06-07),

15. 9345706 - Benzoxazole kinase inhibitors and methods of use (2016-05-24),

INTELLIKINE LLC is a leading biopharmaceutical company focused on discovering and developing innovative small molecule drugs targeting signal transduction pathways. Their team of experienced scientists and researchers work diligently to advance their pipeline of potential therapeutics to address the unmet medical needs of patients. Through cutting-edge technology and a commitment to scientific excellence, INTELLIKINE LLC aims to make a positive impact on the lives of individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

34 Patents

#20 in La Jolla, CA

#2,298 in California

#9,641 in US

#19,028 in the World

La Jolla, CA, United States of America

Intellikine LLC

Forward Citations = 578

54 inventors:

Yi Liu (33 out of 149 patents)

Pingda Ren (32 out of 136 patents)

Troy Edward Wilson (31 out of 55 patents)

4. Liansheng Li (27 out of 114 patents)

5. Katrina Chan (25 out of 47 patents)

Please report any incorrect information to support@idiyas.com

Loading…